Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saar Gill

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Best Practice & Research. Clinical Haematology|November 29, 2016
Chimeric antigen receptor T cell therapy in AML: How close are we?Saar Gill
Science Translational Medicine|February 3, 2017
Monkey business: Repurposing a protein from the simian immunodeficiency virus to enhance cytotoxic chemotherapySaar Gill
Current Hematologic Malignancy Reports|May 4, 2016
Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic MalignanciesSaar Gill
Blood|February 11, 2021
DARTs point the way forward in AMLSaar Gill
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
The Yin and Yang of Alloreactivity: Chronic Graft-versus-Host Disease and Leukemia RelapseSaar Gill
Science Translational Medicine|January 20, 2017
CAR T cells engage in anticancer martial artsSaar Gill
Translational Research : the Journal of Laboratory and Clinical Medicine|December 19, 2012
T cell-based gene therapy of cancerSaar Gill, Michael Kalos
Nature Immunology|September 9, 2024
CD45 threads the needle of cytokine cancer immunotherapyNils Wellhausen, Saar Gill
Leukemia & Lymphoma|February 26, 2008
Therapeutic options in mantle cell lymphomaSaar Gill, David Ritchie
Leukemia & Lymphoma|April 19, 2021
CAR-T cell persistence in the treatment of leukemia and lymphomaArjun Gupta, Saar Gill
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Best Practice & Research. Clinical Haematology|November 29, 2016
Chimeric antigen receptor T cell therapy in AML: How close are we?Saar Gill
Science Translational Medicine|February 3, 2017
Monkey business: Repurposing a protein from the simian immunodeficiency virus to enhance cytotoxic chemotherapySaar Gill
Current Hematologic Malignancy Reports|May 4, 2016
Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic MalignanciesSaar Gill
Blood|February 11, 2021
DARTs point the way forward in AMLSaar Gill
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
The Yin and Yang of Alloreactivity: Chronic Graft-versus-Host Disease and Leukemia RelapseSaar Gill
Science Translational Medicine|January 20, 2017
CAR T cells engage in anticancer martial artsSaar Gill
Translational Research : the Journal of Laboratory and Clinical Medicine|December 19, 2012
T cell-based gene therapy of cancerSaar Gill, Michael Kalos
Nature Immunology|September 9, 2024
CD45 threads the needle of cytokine cancer immunotherapyNils Wellhausen, Saar Gill
Leukemia & Lymphoma|February 26, 2008
Therapeutic options in mantle cell lymphomaSaar Gill, David Ritchie
Leukemia & Lymphoma|April 19, 2021
CAR-T cell persistence in the treatment of leukemia and lymphomaArjun Gupta, Saar Gill
Pageof 10